Loading...

Elaine Ku, MD

Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-476-3546
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Clinical Scientist in Nephrology Award2013  - 2014American Kidney Fund
    Satellite Dialysis Clinical Investigator Grant2016  - 2018National Kidney Foundation

    Collapse Overview 
    Collapse Overview
    EDUCATION
    College: University of California Los Angeles, BS
    Medical School: University of California San Diego, MD
    Medicine-Pediatrics Residency: University of Southern California
    Adult and Pediatric Nephrology Fellowship: University of California San Francisco
    Other Graduate Training: University of California San Francisco, MAS


    INTERESTS
    Dr. Ku's research focuses primarily on hypertension and its long-term sequelae in populations at high cardiovascular risk (chronic kidney disease and diabetes). In addition, Dr. Ku is also interested in understanding the optimal approach to the care of young patients with pediatric-onset chronic kidney disease as they transition into adulthood.


    Collapse Research 
    Collapse Research Activities and Funding
    Blood pressure trends, outcomes, and interventions in adolescents and young adults at increased cardiovascular risk
    NIH K23HL131023Feb 1, 2016 - Jan 31, 2021
    Role: Principal Investigator
    Role of pre-ESRD blood pressure management on post-ESRD outcomes
    NIH F32DK098871Dec 1, 2014 - Nov 30, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY. Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk. J Am Soc Nephrol. 2017 May 04. PMID: 28473636.
      View in: PubMed
    2. Ku E, McCulloch CE, Grimes BA, Johansen KL. Racial and Ethnic Disparities in Survival of Children with ESRD. J Am Soc Nephrol. 2016 Dec 29. PMID: 28034898.
      View in: PubMed
    3. Ku E, Lipkowitz MS, Appel LJ, Parsa A, Gassman J, Glidden DV, Smogorzewski M, Hsu CY. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype. Kidney Int. 2016 Dec 04. PMID: 27927600.
      View in: PubMed
    4. Ku E, McCulloch CE, Mauer M, Gitelman SE, Grimes BA, Hsu CY. Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. Diabetes Care. 2016 Dec; 39(12):2218-2224. PMID: 27872156.
      View in: PubMed
    5. Ku E, Gassman J, Appel LJ, Smogorzewski M, Sarnak MJ, Glidden DV, Bakris G, Gutiérrez OM, Hebert LA, Ix JH, Lea J, Lipkowitz MS, Norris K, Ploth D, Pogue VA, Rostand SG, Siew ED, Sika M, Tisher CC, Toto R, Wright JT, Wyatt C, Hsu CY, et al. BP Control and Long-Term Risk of ESRD and Mortality. J Am Soc Nephrol. 2016 Aug 11. PMID: 27516235.
      View in: PubMed
    6. Ku E, Fine RN, Hsu CY, McCulloch C, Glidden DV, Grimes B, Johansen KL. Height at First RRT and Mortality in Children. Clin J Am Soc Nephrol. 2016 May 6; 11(5):832-9. PMID: 26933189.
      View in: PubMed
    7. Ku E, Xie D, Shlipak M, Hyre Anderson A, Chen J, Go AS, He J, Horwitz EJ, Rahman M, Ricardo AC, Sondheimer JH, Townsend RR, Hsu CY. Change in Measured GFR Versus eGFR and CKD Outcomes. J Am Soc Nephrol. 2016 Jul; 27(7):2196-204. PMID: 26604213.
      View in: PubMed
    8. Ku E, Glidden DV, Hsu CY, Portale AA, Grimes B, Johansen KL. Association of Body Mass Index with Patient-Centered Outcomes in Children with ESRD. J Am Soc Nephrol. 2016 Feb; 27(2):551-8. PMID: 26054540.
      View in: PubMed
    9. Ku E, Johansen KL, Portale AA, Grimes B, Hsu CY. State level variations in nephrology workforce and timing and incidence of dialysis in the United States among children and adults: a retrospective cohort study. BMC Nephrol. 2015; 16:2. PMID: 25589150; PMCID: PMC4361136.
    10. Ku E, Glidden DV, Johansen KL, Sarnak M, Tighiouart H, Grimes B, Hsu CY. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney Int. 2015 May; 87(5):1055-60. PMID: 25493952; PMCID: PMC4425599.
    11. Ku E, Thomas M, Ho CH, Whipple NS, Abdul-Rahman O, Megason GC, Herrington BL, Carmody JB, Charlton JR. Index of suspicion. Case 1: fever, diarrhea, jaundice, and confusion in an 18-year-old male. Case 2: severe anemia in a 6-month-old girl. Case 3: red urine in a 4-month-old boy. Pediatr Rev. 2014 Mar; 35(3):129-35. PMID: 24585816.
      View in: PubMed
    12. Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY. Regional variation in the incidence of dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1476-81. PMID: 23929923; PMCID: PMC3805086.
    13. Ku E, Campese V. Is lipid management effective for all stages of CKD?. Blood Purif. 2013; 35(1-3):26-30. PMID: 23343543.
      View in: PubMed
    14. Ku E, Ananthapanyasut W, Campese VM. IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA. Clin Nephrol. 2012 Feb; 77(2):146-50. PMID: 22257545.
      View in: PubMed
    15. Campese VM, Ku E, Bigazzi R, Bianchi S. Do HMG-CoA reductase inhibitors improve kidney function? The saga continues. J Nephrol. 2011 Sep-Oct; 24(5):550-3. PMID: 21887675.
      View in: PubMed
    16. Campese VM, Ku E, Park J. Sympathetic renal innervation and resistant hypertension. Int J Hypertens. 2011; 2011:814354. PMID: 21331158; PMCID: PMC3034934.
    17. Ku E, Brotherton BJ, Parrish C, Zia SK, McKenna S. Visual diagnosis: vaginal mass in a 16-month-old child. Pediatr Rev. 2010 Aug; 31(8):337-40. PMID: 20679100.
      View in: PubMed
    18. Lu Y, Ku E, Campese VM. Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Curr Hypertens Rep. 2010 Aug; 12(4):303-6. PMID: 20596805.
      View in: PubMed
    19. Ku E, Campese VM. Aldosterone and hypertension in African Americans. Am J Hypertens. 2009 Dec; 22(12):1234. PMID: 19924116.
      View in: PubMed
    20. Ku E, Cheung EL, Khan A, Yu AS. Anion and osmolal gaps after alcohol intoxication. Am J Kidney Dis. 2009 Aug; 54(2):385-8. PMID: 19560850.
      View in: PubMed
    21. Ku E, Park J, Vidhun J, Campese V. The hazards of dual renin-angiotensin blockade in chronic kidney disease. Arch Intern Med. 2009 Jun 8; 169(11):1015-8. PMID: 19506167.
      View in: PubMed
    22. Ku E, Nobakht N, Campese VM. Lixivaptan: a novel vasopressin receptor antagonist. Expert Opin Investig Drugs. 2009 May; 18(5):657-62. PMID: 19379124.
      View in: PubMed
    23. Ku E, Campese VM. Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children. Pediatr Nephrol. 2009 Dec; 24(12):2301-7. PMID: 19347366.
      View in: PubMed
    Elaine's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP